Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M20,448Revenue (TTM) $M2,253Net Margin (%)18.4Altman Z-Score8.8
Enterprise Value $M20,207EPS (TTM) $2.8Operating Margin %24.8Piotroski F-Score6
P/E(ttm)50.0Beneish M-Score-2.5Pre-tax Margin (%)23.1Higher ROA y-yN
Price/Book10.310-y EBITDA Growth Rate %--Quick Ratio3.7Cash flow > EarningsY
Price/Sales9.25-y EBITDA Growth Rate %24.8Current Ratio4.3Lower Leverage y-yY
Price/Free Cash Flow43.9y-y EBITDA Growth Rate %-1.8ROA % (ttm)11.3Higher Current Ratio y-yY
Dividend Yield %--PEG2.0ROE % (ttm)22.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M147ROIC % (ttm)27.4Gross Margin Increase y-yN

Gurus Latest Trades with ILMN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ILMNJulian Robertson 2016-03-31 Sold Out -2.56%$135.37 - $191.95
($157.69)
$ 138.91-12%Sold Out0
ILMNSteve Mandel 2016-03-31 Reduce-1.59%$135.37 - $191.95
($157.69)
$ 138.91-12%Reduce -53.59%1,675,158
ILMNRon Baron 2016-03-31 Reduce-0.16%$135.37 - $191.95
($157.69)
$ 138.91-12%Reduce -12.52%1,228,286
ILMNGeorge Soros 2016-03-31 Sold Out -0.01%$135.37 - $191.95
($157.69)
$ 138.91-12%Sold Out0
ILMNJulian Robertson 2015-12-31 Reduce-1.3%$140.17 - $194.18
($166.62)
$ 138.91-17%Reduce -34.89%103,200
ILMNVanguard Health Care Fund 2015-12-31 Reduce-0.09%$140.17 - $194.18
($166.62)
$ 138.91-17%Reduce -7.86%2,787,466
ILMNRon Baron 2015-12-31 Reduce-0.04%$140.17 - $194.18
($166.62)
$ 138.91-17%Reduce -3.74%1,404,071
ILMNGeorge Soros 2015-12-31 Buy 0.01%$140.17 - $194.18
($166.62)
$ 138.91-17%New holding2,100
ILMNSteve Mandel 2015-09-30 Reduce-1.69%$167.51 - $240.02
($208.03)
$ 138.91-33%Reduce -36.43%3,609,735
ILMNJulian Robertson 2015-09-30 Add0.91%$167.51 - $240.02
($208.03)
$ 138.91-33%Add 32.19%158,500
ILMNVanguard Health Care Fund 2015-09-30 Add0.24%$167.51 - $240.02
($208.03)
$ 138.91-33%Add 26.02%3,025,105
ILMNRon Baron 2015-09-30 Reduce-0.04%$167.51 - $240.02
($208.03)
$ 138.91-33%Reduce -3.35%1,458,569
ILMNSteve Mandel 2015-06-30 Add2.28%$182.21 - $220.75
($200.55)
$ 138.91-31%Add 96.48%5,678,537
ILMNJulian Robertson 2015-06-30 Add0.52%$182.21 - $220.75
($200.55)
$ 138.91-31%Add 16.41%119,900
ILMNRon Baron 2015-06-30 Add0.25%$182.21 - $220.75
($200.55)
$ 138.91-31%Add 23.70%1,509,065
ILMNVanguard Health Care Fund 2015-06-30 Add0.2%$182.21 - $220.75
($200.55)
$ 138.91-31%Add 24.20%2,400,500
ILMNJoel Greenblatt 2015-06-30 Sold Out -0.02%$182.21 - $220.75
($200.55)
$ 138.91-31%Sold Out0
ILMNSteve Mandel 2015-03-31 Buy 2.03%$180.91 - $203.25
($193.62)
$ 138.91-28%New holding2,890,103
ILMNRon Baron 2015-03-31 Reduce-0.13%$180.91 - $203.25
($193.62)
$ 138.91-28%Reduce -13.37%1,219,938
ILMNJoel Greenblatt 2015-03-31 Add0.01%$180.91 - $203.25
($193.62)
$ 138.91-28%Add 79.87%13,069
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ILMN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ILMN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BOWMAN A BLAINEDirector 2016-06-16Sell5,000$135.082.84view
HENRY CHRISTIAN OEVP & Chief Commercial Officer 2016-06-15Sell2,141$137.90.73view
WHITFIELD ROY ADirector 2016-06-13Sell3,800$140.44-1.09view
EASTHAM KARINDirector 2016-06-01Sell5,000$145.35-4.43view
HENRY CHRISTIAN OEVP & Chief Commercial Officer 2016-05-25Sell2,141$144.73-4.02view
HENRY CHRISTIAN OEVP & Chief Commercial Officer 2016-05-17Sell2,141$140.84-1.37view
BOWMAN A BLAINEDirector 2016-05-12Sell5,000$137.111.31view
HENRY CHRISTIAN OEVP & Chief Commercial Officer 2016-04-27Sell2,141$138.460.33view
HENRY CHRISTIAN OEVP & Chief Commercial Officer 2016-04-18Sell2,141$176.01-21.08view
Bianchi Paul LSr. VP, Human Resources 2016-04-18Sell1,884$175-20.62view

Press Releases about ILMN :

Quarterly/Annual Reports about ILMN:

News about ILMN:

Articles On GuruFocus.com
Baron Funds Comments on Illumina Inc. May 23 2016 
Baron Funds Comments on Illumina May 06 2016 
Baron Funds Comments on Illumina Inc. Apr 26 2016 
Should You Wait to Bet on Agilent Technologies? Dec 20 2015 
Julian Robertson Keeps Buying Citigroup, Netflix, Facebook Dec 07 2015 
Halvorsen's Investment Makes Broadcom His Fifth-Most Valuable Stake Dec 05 2015 
Barron Asset Fund Third Quarter Letter - Part One Nov 02 2015 
Baron Funds Comments on Illumina Inc. Nov 02 2015 
Halvorsen Buys Amazon, Sells Out Micron Technology During Q2 Oct 05 2015 
Ron Baron's Largest Purchases During Second Quarter Sep 28 2015 

More From Other Websites
Steve Mandel Exits Position in Williams Companies in 1st Quarter Jun 24 2016
Illumina, Inc. breached its 50 day moving average in a Bullish Manner : ILMN-US : June 24, 2016 Jun 24 2016
Coverage initiated on Illumina by CL King Jun 22 2016
10 Stocks to Buy Now From the World's Best Stock Pickers Jun 18 2016
Jay Flatley created a market for DNA sequencing from scratch — and the result is the largest... Jun 17 2016
Illumina Announces Initial Customer Orders for the Global Screening Array Jun 16 2016
The Ingenious Moneymaking Method of the World's Super Investors: Buffett, Lynch, Icahn Jun 10 2016
Germ Sleuths Go High-Tech as Labs Get Illumina Sequencers Jun 08 2016
'Mad Money' Lightning Round: Buy, Buy, Buy Time Warner Jun 08 2016
Cramer: Uber has completely destroyed the car rental industry Jun 07 2016
Illumina Announces Donald Danforth Plant Science Center to Receive Agricultural Greater Good... Jun 07 2016
What's The Single Best $10,000 Investment To Hold For The Next 25 Years? Jun 04 2016
Illumina Appoints Paula Dowdy Senior Vice President and General Manager of Commercial Operations for... Jun 02 2016
How to Discover the Best Biotechs in the World May 31 2016
New Strong Sell Stocks for May 26th May 26 2016
Illumina to Webcast Live Presentation at Upcoming Investment Conferences in June May 25 2016
ILLUMINA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 19 2016
ILLUMINA INC Financials May 14 2016
Short Interest Surges In Illumina And Vertex Pharmaceuticals May 13 2016
Illumina: Q1 Results Hit by Soaring Costs; '16 View Down May 12 2016
Illumina Registers MiSeqDx System in South Korea May 09 2016
Collaborative Study of Whole Exome Sequencing Offers New Hope for Children with White Matter... May 09 2016
Illumina misses Street 1Q forecasts May 03 2016
Premaitha Health patent dispute reaches new level Apr 21 2016
Illumina shares tumble after revised revenue estimate Apr 19 2016
US close: Stocks gain after FOMC meeting minutes Apr 07 2016
BIOMED REALTY ANNOUNCES ILLUMINA, INC., AS SOLE TENANT FOR SAN DIEGO i3 CAMPUS Apr 05 2016
US STOCKS-Oil drop, China data drag Wall Street lower Mar 08 2016
US close: Wall Street finishes on mixed note Feb 29 2016
US close: Stocks slip as oil futures come under pressure Feb 19 2016
Genomics England Enters Bioinformatics Partnership with Illumina Feb 11 2016
Former Google executive to lead cancer diagnostics firm Feb 10 2016
Former Google executive to lead cancer diagnostics firm Feb 10 2016
Illumina misses 4Q profit forecasts Feb 02 2016
Illumina Signs Multiple Biobank Deals Feb 01 2016
Illumina Appoints Dr. Frances Arnold to Its Board of Directors Jan 28 2016
Illumina to Announce Fourth Quarter and Fiscal Year 2015 Financial Results on Tuesday, February 2,... Jan 19 2016
Illumina Files Two Patent Infringement Suits in Europe for Infringement of Patents for NIPT Jan 19 2016
Illumina Extends Genomics Portfolio Jan 19 2016
Illumina to Host Investor Call on Sunday, January 10, 2016 Jan 19 2016
Bio-Rad and Illumina to Co-Develop Comprehensive Solution for Single-Cell Genomics Jan 19 2016
Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening Jan 19 2016
Bio-Rad and Illumina to Co-Develop Comprehensive Solution for Single-Cell Genomics Jan 11 2016
Illumina Files Two Patent Infringement Suits in Europe for Infringement of Patents for NIPT Jan 07 2016
bioMérieux and Illumina announce the launch of bioMérieux EpiSeq™, a revolutionary... Dec 14 2015
Novogene and Illumina to Co-Develop NGS Diagnostic System for Reproductive Health and Oncology... Dec 14 2015
Illumina Accelerator Announces Third Funding Cycle of Genomics Startups Dec 09 2015
Desktop Genetics Receives Strategic Investment from Illumina to Advance Genome Editing Software... Dec 09 2015
Desktop Genetics Receives Strategic Investment from Illumina to Advance Genome Editing Software... Dec 09 2015
US close: Stocks mixed on quiet day of Thanksgiving trading Nov 27 2015
Illumina Announces New $250 Million Share Repurchase Authorization Nov 02 2015
Clarification: Earns-Illumina story Oct 22 2015
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2015 Oct 20 2015
Illumina tops 3Q profit forecasts Oct 20 2015
Illumina Announces Preliminary Revenue for Third Quarter of Fiscal Year 2015 Oct 05 2015
US stocks end flat ahead of jobs report Oct 01 2015
Amoy Diagnostics and Illumina Enter Strategic Collaboration for Next-Generation Sequencing Cancer... Sep 30 2015
Illumina beats 2Q profit forecasts Jul 21 2015
Amazon, Google race to get your DNA into the cloud Jun 05 2015
Corrected - Amazon, Google race to get your DNA into the cloud Jun 05 2015
Illumina beats Street 1Q forecasts Apr 21 2015
Illumina beats Street 4Q forecasts Jan 27 2015
Sequenom climbs as Illumina patent dispute ends Dec 03 2014
Illumina beats Street 3Q forecasts Oct 20 2014

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)